VolitionRx Limited (VNRX)

VolitionRx Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023
Revenue	1.73	1.23	0.78
Revenue Growth (YoY)	40.04%	59.10%	-
Gross Profit	1.73	1.23	0.78
Selling, General & Admin	13.38	13.85	17.21
Research & Development	10.08	14.41	19.55
Total Operating Expenses	23.47	28.26	36.76
Operating Income	-21.74	-27.02	-35.99
Interest Income	0	0.01	0.09
Interest Expense	-0.53	-0.34	-0.22
Other Non-Operating Income (Expense)	-1.23	0.1	0.44
Total Non-Operating Income (Expense)	-1.76	-0.23	0.31
Pretax Income	-23.5	-27.26	-35.68
Net Income	-23.36	-26.97	-35.32
Minority Interest in Earnings	-0.15	-0.29	-0.36
Net Income to Common	-23.36	-26.97	-35.32
Shares Outstanding (Basic)	107	87	71
Shares Outstanding (Diluted)	107	87	71
Shares Change (YoY)	23.46%	21.47%	-
EPS (Basic)	-0.22	-0.31	-0.50
EPS (Diluted)	-0.22	-0.31	-0.50
Shares Outstanding	125.78	96.1	81.9
Free Cash Flow	-19.77	-26.17	-19.15
Free Cash Flow Per Share	-0.19	-0.30	-0.27
Gross Margin	100.00%	100.00%	100.00%
Operating Margin	-1258.47%	-2190.90%	-4641.76%
Profit Margin	-1360.63%	-2209.79%	-4601.70%
FCF Margin	-1144.67%	-2121.68%	-2469.59%
EBITDA	-20.75	-25.91	-34.84
EBITDA Margin	-1201.52%	-2100.65%	-4493.11%
EBIT	-21.74	-27.02	-35.99
EBIT Margin	-1258.47%	-2190.90%	-4641.76%

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q